Skip to main content

Find Clinical Trials

Home
Conditions
Insulin Resistance

Clinical trial condition

Insulin Resistance

Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.

2,345 public trials 206 recruiting studies

Refine in advanced search Browse all conditions

Insulin Resistance trial results

Completed

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

NCT04926415

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
Locations: Burrell College of Osteopathic Medicine Las Cruces, New Mexico, United States

View Trial Details

Completed

Lactobacillus Rhamnosus and PCOS Treatment

NCT03902301

Conditions: 46, XX Disorders of Sex Development, Adnexal Diseases, Adrenogenital Syndrome, +30 more
Locations: Poznan University of Life Sciences Poznan, Poland

View Trial Details

Completed

Coronary Artery Disease Progression in Patients With Prediabetes

NCT02744976

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +14 more
Locations: Pauls Stradins Clinical University hospital Riga, Latvia

View Trial Details

Completed

The Wellness Transformation Network Pilot Study

NCT05314036

Conditions: Behavior, Breast Feeding, Diabetes Mellitus, +10 more
Locations: SNI Clinical Research Winnipeg, Manitoba, Canada

View Trial Details

Completed

Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

NCT02194595

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations: Mount Sinai Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Cardiometabolic Outcomes With Light Exposure During Sleep

NCT05317559

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
Locations: Not specified

View Trial Details

Completed

Comparing Metabolic Characteristics of Persistent Critically Ill Non-COVID and COVID-19 Patients

NCT05026151

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Hypophosphatemia, +8 more
Locations: Lausanne University Hospital - CHUV Lausanne, Canton of Vaud, Switzerland

View Trial Details

Completed

Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis

NCT02930044

Conditions: Acid-Base Imbalance, Acidosis, Diabetes Complications, +13 more
Locations: University of Maryland Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Gan & Lee Insulin Glargine Target Type (2) Evaluating Research

NCT03371108

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations: Simon Williamson Clinic Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

Terence T. Hart, MD Tuscumbia, Alabama, United States

Family Practice Specialists Phoenix, Arizona, United States

View all 57 locations

View Trial Details

Completed

Modification of Gut Microbiota in the Treatment of Insulin Resistance: a Personalized Approach

NCT03710850

Conditions: Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +5 more
Locations: University Hospital Kralovske Vinohrady Prague, Czechia

View Trial Details